 |
| BY READING THIS EMAIL YOU CERTIFY YOU HAVE READ THE DISCLAIMER BELOW AND THE FULL DISCLAIMER PROVIDED THROUGH A LINK AT THE END OF THIS EMAIL. This is a paid advertisement. SmallCapVoice.com, Inc. is not responsible or held liable for the information in the press releases issued by the companies in these emails. Please always do your own due diligence. |
|---|
|
   |
| INQD Volume Up on News PSID Announces Q1 Highlights |
|
 Yesterday's Top Performer
|
Company: Indoor Harvest Corp. (OTCQB: INQD)
|
End of Day:
Price: 0.97
Change (%): + 0.06 (6.59)
Volume: 4,300 |
 |
Indoor Harvest Corp and PUE 1.0 sign Letter of Intent to Develop New HVAC Systems for Building Integrated Agriculture and Vertical Farming
HOUSTON, April 15, 2015 /PRNewswire/ - Indoor Harvest, Corp (OTCQB:INQD), through its brand name Indoor Harvest™, is a design build contractor, developer, marketer and direct-seller of commercial grade aeroponic and hydroponic fixtures and supporting systems for use in urban Controlled Environment Agriculture and Building Integrated Agriculture. The Company is pleased to announce it has executed a letter of intent with PUE 1.0 to design and build an engineered HVAC system for use in building integrated agriculture. Both parties agreed to work to a final, binding agreement in good faith as quickly as possible.
Indoor Harvest’s CEO and founder Chad Sykes commented, “This relationship, when finalized, will allow us to quickly round out our mechanical services by including HVAC systems. With a portfolio of existing designs for cultivation systems, including one patent pending, adding HVAC would position us to offer entire turn-key mechanical solutions for the indoor farming industry. We believe that the most important aspect of indoor farming is the HVAC system and that it’s been one area that has not seen any significant technological advances. By taking PUE 1.0’s existing proven HVAC system for the data center industry and adapting it to indoor farming, we’re hoping to be the first company to introduce a fully engineered, highly efficient indoor farming HVAC system.”
Continue Reading
|
 Hot Stock to Watch
|
Company: PositiveID Corporation (OTCQB: PSID)
|
End of Day:
Price: 0.0228
Change (%): - 0.0011 (4.60)
Volume: 5,508,405 |
 |
PositiveID Announces First Quarter Highlights
Company Makes Significant Progress in First Quarter With Firefly Dx Development and Testing; Achieves PCR Results in Less Than 20 Minutes on PCR Chip
DELRAY BEACH, Fla., April 15, 2015 (GLOBE NEWSWIRE) - PositiveID Corporation (“PositiveID” or “Company”) (OTCQB:PSID), a developer of biological detection and diagnostics solutions, today announced its first quarter highlights, primarily related to the Company’s continued progress with the development and testing of its Firefly Dx, a handheld, point-of-need, real-time PCR (polymerase chain reaction) pathogen detection system.
“As we continue to advance the development and testing of Firefly Dx, which is being built to capitalize on a multi-billion dollar market opportunity and unmet requirement for point-of-need, real-time PCR testing, we are excited with our progress to date and the opportunity to deliver a system that could revolutionize the way biological samples are tested, while delivering significant value to our stockholders,” stated William J. Caragol, Chairman and CEO of PositiveID.
Continue Reading |
Other Small Cap News
|
Company: Nutra Pharma Corp. (Pink Sheets: NPHC)
|
Nutra Pharma Provides Updates on Marketing and Distribution of Nyloxin® to India
Nutra Pharma Is Providing an Update on the Company's Efforts to Market and Distribute Their Over-the-Counter (OTC) Pain Reliever, Nyloxin® in India
CORAL SPRINGS, FL--(Marketwired - Apr 15, 2015) - Nutra Pharma Corp. (OTC: NPHC), a biotechnology company that is developing treatments for Adrenomyeloneuropathy (AMN), HIV and Multiple Sclerosis (MS), is providing an update regarding their plan to market their over-the-counter (OTC) pain reliever, Nyloxin® through S.Zhaveri Pharmakem for distribution throughout India. Nutra Pharma previously announced that they had shipped their initial test orders of Nyloxin® in February to ensure Customs clearance before escalating order sizes and frequency. Nutra Pharma management has been working in Mumbai this week to finalize their plans for the national rollout of Nyloxin.
"Now that we have successfully sent test shipments of our products to our partners in India, I needed to travel to Mumbai this week to work on the next steps that we will take to maximize the potential of this enormous market," stated Rik J. Deitsch, Chairman and CEO of Nutra Pharma Corporation.
Continue Reading
|
Company: Nutroganics, Inc. (Pink Sheets: NUTT)
|
Nutroganics, Inc. (NUTT) Announces Launch of Tempo™ Brand; Thomas Prehn to Lead New Product Marketing; Update on Q1 EBITDA and Net Income; Raises Guidance
BETHESDA, MD--(Marketwired - Apr 15, 2015) - Nutroganics, Inc. (OTC PINK: NUTT) ("Nutroganics") announces that Thomas Prehn, a former professional cyclist and endurance sports expert, has joined the Company to help launch Nutroganics' new endurance sports nutrition and lifestyle brand, Tempo™. Thomas is based in Colorado and has been a prominent figure in the endurance sports community for 35 years.
David Sackler, Nutroganics' President & CEO, said, "We are pleased to have Thomas join us and bring his wealth of relationships and knowledge in the endurance sports industry. He will help us advise our existing clients and assist with the launch of our branded endurance sports nutrition system, Tempo™."
Continue Reading |
Market News
|
By Alex Rosenberg: CNBC
|
This obscure indicator is a ‘significant concern’
Most investors have never heard of the three-month volatility index, which is known as the VXV. But the relationship between the CBOE three-month volatility index and the options exchange's more familiar 30-day volatility index, the VIX, may signal trouble for stocks.
Like the VIX, the VXV is a measure of expected volatility in the S&P 500 that is computed from the prices of options on the index. However, while the VIX measures expected volatility over the next 30 days, the VXV measures expected volatility over the next 93 days.
By comparing the two, an important indicator is formed, according to Bank of America Merrill Lynch technician MacNeil Curry.
Continue Reading
|
By Michael Palmer: Stansberry Research
|
Developing Story: Dr. Ron Paul Reveals #1 Step to Prepare for America’s Next Big Crisis
WASHINGTON, D.C. - This is a fascinating story with implications for every American...
Dr. Ron Paul-the former U.S. Presidential candidate and 22-year Congressional veteran-was briefly back in Washington, D.C., recently.
Dr. Paul was in the nation’s capital to educate Americans on what he believes our country’s next financial crisis will look like.
Continue Reading
|
  |
IMPORTANT DISCLAIMER - PLEASE READ THOROUGHLY
SmallCapVoice (SCV) is an electronic publication. Information sources for our profiles include, but are not limited to, online research, member suggestions, magazines, newspapers, analyst suggestions, publicly available material information provided by the profiled company, press releases and similar sources. This communication is not an offer to sell or a recommendation that you buy or sell any security. SCV holds no securities licenses and is not qualified to provide investment advice. We are compensated for these advertisements by the profiled companies. You should not use this newsletter as the sole basis for any investment decision. While all investments involve risk, microcap stocks are among the most risky. Many microcap companies have no proven track record. You should only invest in microcap companies if you can afford to lose your entire investment. You should consult a qualified, licensed financial advisor or stock broker before making any decisions to invest in the securities of any company that is described in these profiles. These profiles are paid advertisements. Although we have a reasonable belief that the information in each profile is accurate, we cannot guarantee that this information, which originates from third parties, is accurate. We do not have the resources to confirm the accuracy of all information obtained from third parties. It is important for you to verify all information by your own independent research. You are receiving this message because you have agreed to receive emails from SmallCapVoice.com. You may opt out of our distribution list at any time by clicking on the “unsubscribe” link below. Link to full disclosure about compensation paid to SmallCapVoice.com, Inc. by companies featured on our website or in our e-mail communications. |
About Penny Stocks |
|
|
